ASX 200 up 0.4%: Altium disappoints, ARB impresses, Mesoblast charges higher

Altium Limited (ASX:ALU) and Mesoblast limited (ASX:MSB) shares are on the move on the ASX 200 on Tuesday…

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

At lunch on Tuesday the S&P/ASX 200 Index (ASX: XJO) is defying the declines on Wall Street and pushing higher. The benchmark index is currently up 0.4% to 6,722.6 points.

Here's what has been happening on the market today:

ASX 200 shares

Image source: Getty Images

Altium guidance disappoints.

The Altium Limited (ASX: ALU) share price has come under pressure on Tuesday after the release of an update on its expectations for the first half of FY 2021. The electronic design software provider revealed that COVID-19 has impacted its sales in the United States and Europe during the half. As a result, it is expecting to deliver revenue of around US$89.6 million for the six months. This will be down 3% on the prior corresponding period.

ARB update impresses

The ARB Corporation Limited (ASX: ARB) share price is racing higher today following the release of its guidance for the first half. The 4×4 accessories company expects to report a 21.6% increase in sales to $284 million and profit before tax of $70 million to $72 million. The latter includes $9.8 million of non-recurring government assistance. Though, even if you exclude this, the company's profit before tax is more than 75% higher than the prior corresponding period.

Mesoblast share price pushes higher.

The Mesoblast limited (ASX: MSB) share price climbing higher again on Tuesday after recording a strong gain yesterday. Investors have been buying the biotech company's shares after its run of disappointing updates came to an end. On Monday Mesoblast announced that its rexlemestrocel-L drug provides a reduction in heart attacks, strokes, and cardiac death in patients with chronic heart failure.

Best and worst ASX 200 performers.

The best performer on the ASX 200 today with a 5% gain has been the ARB share price. This follows its aforementioned guidance update for the first half of FY 2021. The worst performer has been the PolyNovo Ltd (ASX: PNV) share price with a 12% decline. Investors have been selling the medical device company's shares after the release of an underwhelming trading update.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Altium. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of POLYNOVO FPO. The Motley Fool Australia has recommended ARB Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Share Market News

Testing again

Read more »

Share Market News

Aaron Test 2

Read more »

Share Market News

Aaron Test

Read more »

Share Market News

JP Test

Read more »

Share Market News

JP Test

Read more »

Portrait of Discovery Fund portfolio managers Mark Devcich and Chris Bainbridge
Share Market News

Test

Portfolio managers Mark Devcich (left) and Chris Bainbridge. Image source: Discovery Fund test test

Read more »

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.
Share Market News

Another ASX 200 company has been hit with a cyber incident. Here's what we know

Hackers have breached the systems of this ASX 200 company.

Read more »

a woman
Broker Notes

5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Read more »